American Virtual Cloud (AVCT)

Technical Analysis Historical Data Financials News & Analysis

AVCT NEWS

Avacta Therapeutics Presents Data from Lead pre|CISION® Candidate FAP-Dox (AVA6000) at the 2025 AACR Annual Meeting By AVACTA - 4 days ago

Compelling Phase 1 safety and efficacy data for FAP-Dox (AVA6000) with preliminary evidence of efficacy in salivary gland cancers and no severe cardiac toxicity Progression free survival (PFS) data … [+5414 chars]...

Read more
Top Stock
CurrencyPrice Chg
BA 		185.76 2.87
1.57%
CVX 		136.8 0.54
0.4%
CAT 		320.99 7.03
2.24%
INTC 		20.28 0.3
1.51%
MSFT 		434.35 8.95
2.1%
DIS 		92.55 1.74
1.92%
DOW 		30.64 0.11
0.34%
CSCO 		58.85 0.73
1.26%
GS 		562.6 8.77
1.58%